tiprankstipranks
Leadership Changes at Tianjin Pharmaceutical Da Ren Tang
Company Announcements

Leadership Changes at Tianjin Pharmaceutical Da Ren Tang

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.

Don't Miss our Black Friday Offers:

Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. has appointed Ms. Wang Lei as the new Chairman of the Board and Mr. Xing Jianhua as a Director. These leadership changes were decided at the company’s 9th Board meeting for the fiscal year 2024, reflecting the company’s strategic direction and governance.

For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Singapore Auto-Generated NewsdeskTianjin Pharmaceutical Appoints New Supervisory Member
TipRanks Singapore Auto-Generated NewsdeskTianjin Pharmaceutical Hosts First FY2024 Meeting
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App